globeandmail.com
    globeandmail.com/globe-investor/portfolio-and-tools

Renaissance Glob Sci and Tech F USD
  Profiles Help     Click here to print this page

Fund Sponsor: CIBC Asset Management
Portfolio Manager:
Fund Type: Open-Ended

Asset Class: Global Equity
5-Star Rating:
RRSP Eligible: Yes

Inception Date: December, 2000
Total Assets: n/a
Sales Fee Type: No Load
Mgmt Expense Ratio (MER): 1.81%
Closed: No

Min. Invest (initial):
Subsequent:
Min. Invest (initial RRSP):
Subsequent RRSP:
Restricted: No


Statistics


As of July 16, 2018

Current Price: $8.30
Daily Change $: -$0.04
1 day: -0.46%
7 day: 0.96%
Month-to-Date: 3.78%
30 day: 0.86%
Year-to-Date: 16.26%

Returns as of June 30, 2018
Fund Group Avg Index*
1 month 0.52% 0.79% 1.40%
3 month 6.99% 1.84% 4.00%
6 month 12.02% 2.01% 5.78%
1 year 29.65% 8.03% 13.14%
3 year 17.63% 6.77% 11.01%
5 year n/a 10.25% 15.54%
10 year n/a 6.18% 9.68%
15 year n/a 6.38% 8.49%
20 year n/a 4.15% 5.16%
Since Inception n/a n/a n/a
3 year risk 13.55 10.13 9.92
3 year beta n/a n/a 1.00
* Index refers to MSCI World TR CAD

Top Holdings as of Jun 29, 2018
Facebook Inc Ord       8.10%
Microsoft Corp Ord       8.01%
Amazon.Com Inc Ord       5.76%
Visa Inc Ord       5.17%
Mastercard Inc Ord       4.73%
Apple Computer       4.41%
Tencent Holdings Ltd Ord       4.15%
Adobe Systems Inc Ord       4.07%
NVIDIA Corp Ord       3.84%
Google Inc Cl A Ord       3.38%
Extras

Fund Report
Review and compare the current price and performance of all CIBC Asset Management

Charting
Generate different performance charts for this Mutual Fund

PDF Fund Profile
Generate a full-color, print-ready profile in PDF format for this Mutual Fund

Fund Codes & Fees
View fund code, load type, trailer fee and fee schedule data for this Mutual Fund.

Fund Price History
View a 30-day price history for this fund


Investment Objectives
To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. We will not change the Funds fundamental investment objectives without the consent of unitholders by a majority of votes cast at a meeting of unitholders.

Portfolio Composition
as of Jun 29, 2018

Sector Weightings
as of Jun 29, 2018

Stock 92.21% Information Technology 70.67%
Bond 6.04% Health Care 15.78%
Cash and Short Term Securities 1.75% Consumer Discretionary 5.76%
Other 0.00%

Portfolio Manager(s)